Industry Leading Insights

Our reports and articles feature research and analysis on topics that matter most in digital health today.

As technology continues to influence healthcare, our insights are designed to help you understand what comes next and make better decisions in digital health.  

Our Latest Report

Our Latest Tool

Unlocking the Value of Digital Measures in Drug Development

By embracing digital measures, pharma can accelerate drug development, improve patient outcomes. Pharma can and will continue to compete on assets, but should not compete on (digital) endpoints. We require industry collaborations in order to usher in a new era of medicine.

Digital measures have the potential to revolutionise drug development. However, pharma has been slow to fully utilise these measures due to their high costs and lack of standardised applications across therapeutic areas. 

This report presents an expert-led analysis of the state of digital measures in drug development. More specifically, the report delves into:

  • Defining digital measures and the need for standardisation
  • Benefits and challenges of digital measures in drug development
  • Current and future adoption of digital measures in drug development 
  • How pharmaceutical companies can drive the adoption of digital measures  

Download the report to learn what our HealthXL community experts believe is in store for the future of digital measures in drug development and how best to prepare for it. 

Download the free tool nowDownload the free report now
View all reports

Blog

Explore our latest thinking, expert analysis and community insights on what matters most in digital health.

February 16, 2024

Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024

2024 has been off to a great start at HealthXL, with topics ranging from How to Scale Partnerships Between Lifesciences and Digital Health Companies? to Real World Data in Clinical Trials: Benefits and Best Practices.

Read more
February 2, 2024

AI in Clinical Trials: Navigating the Trial-and-Error Process

AI holds the promise of revolutionising clinical trials, specifically by automating and optimising critical processes. The technology has the capability to significantly boost productivity, cut costs, and accelerate the overall timeline of clinical trials. 

Read more
January 6, 2024

Leading with Thoughts on Digital Health: A Review of HealthXL Reports

Many of you may still be relishing in the holiday bliss, but for HealthXL, the new year is already in full swing. Before we properly close the door on last year, I wanted to take a minute (or so …) to reflect on the tumultuous year that has been.

Read more
View all articles